Mithra Pharmaceuticals SA NV

Mithra Pharmaceuticals S...: Company Financial Information

 Company name  Mithra Pharmaceuticals SA    ISIN:  BE0974283153
 End of Fiscal Year:  31 December 2015    Founded Year:  2015

Mithra Pharmaceuticals S...

(at previous day's close)
Market Cap. 740.89 m
Shares In Issue 31.13 m
Prev. Close 23.95
PE Ratio -61.41  
Dividend Yield - %
EPS – basic -0.39 c
Dividend PS - c
Dividend Cover -
Cash Flow PS -0.60 c
Return On Equity (ROE) -14.78 %
Operating Margin - %
PEG Factor -  
EPS Growth Rate - %
Dividend PS Growth Rate - %
Net Debt -18.60 m
Gross Gearing 38.03 %
Quick Assets 104.58 m
Net Working Cap 171.05 m
Intangibles / Fixed Assets 435.61 %
Turnover PS 0.66 c
Pre-Tax Profit PS -0.00 c
Retained Profit PS - c
Cash PS 310.94 c
Net Cash PS 199.98 c
Net Tangible Asset Value PS* 0.64 c
Net Asset Value PS 660.42 c
Spread 0.10 (0.42%)

Mithra Pharmaceuticals S... Balance Sheet (31 Dec 2015)

MITRA:liab eqMITRA:assets

Mithra Pharmaceuticals S... Share Price

Sample Period  High Low
1 week 23.20 24.50
4 weeks 22.85 24.50
12 weeks 22.10 28.95
1 year 17.42 28.95

Mithra Pharmaceuticals S... (5 years)

Mithra Pharmaceuticals S... Historic Returns

Period *  Open Change % Open Avg. Avg. Daily Vol [m] Total Vol. [m] VWAP
1 week 23.65 0.15 0.63 24.13 50,486.00 24.13
4 weeks 23.50 0.30 1.28 23.56 47,173.00 23.61
12 weeks 25.10 -1.30 -5.18 24.40 105,089.00 25.09
26 weeks 19.84 3.96 19.96 22.25 84,479.00 23.15
1 year 21.40 2.40 11.21 20.03 71,727.00 21.13
3 years 31.30 -7.50 -23.96 24.45 67,490.00 24.54
5 years 8.80 15.00 170.45 19.47 57,850.00 23.05

Mithra Pharmaceuticals S... Key Management Ratio

Mithra Pharmaceuticals S... Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio -39.80  
PE Ratio -61.41  
Tobin's Q Ratio -  
Tobin's Q Ratio (excl. intangibles) -  
Dividend Yield - %
Market-to-Book Ratio 3.63  
Price-to-Pre-Tax Profit PS -628,791.14  
Price-to-Retained Profit PS -  
Price-to-Cash Flow PS -39.93  
Price-to-Sales PS 36.48  
Price-to-Net Tangible Asset Value PS 37.65  
Price-to-Cash PS 0.08  
Net Working Capital PS 5.49  
Price Pct to Working Capital PS 4.36 %
Earnings Yield - %
Average PE -  
Years in Average PE -  
PE to PE average - %

Mithra Pharmaceuticals S... Financial Ratios

(Leverage Ratios)
Debt Ratio -23.79 %
Debt-to-Equity Ratio -0.15  
Debt-to-Equity Ratio (excl. Intgbl) -0.45  
Debt-to-Equity Market Value -0.03  
Net Gearing -9.05 %
Net Gearing (excl. Intangibles) -15.59 %
Gross Gearing 38.03 %
Gross Gearing (excl. Intangibles) 65.52 %
Gearing Under 1 Year 16.80 %
Gearing Under 1 Year (excl. Intgbl) 28.94 %
Assets / Equity 1.61  
Cash / Equity 0.76  
(Liquidity Ratios)
Net Working Capital to Total Assets 83.20 %
Current Ratio 0.65  
Quick Ratio (Acid Test) 0.57  
Liquidity Ratio 2.80  
Cash & Equiv / Current Assets 433.18 %
(Solvency Ratios)
Enterprise Value 6,877.47 m
Sales -0.91  
CFO / Attributable Profit -  
CFO / Assets -0.00  
CFO / Debt -0.00  
Total Debt / Equity Market Value 0.11  
Total Debt / Sales 3.83  
Total Debt / Pre-Tax Profit -6,594,669.82  
Total Debt 78.19 m
Total Debt / Net Current Assets 0.46 %
(Dodds – Graham Ratios)
3 yr Compound Earnings Growth - %
5 yr Compound Earnings Growth - %
10 yr Compound Earnings Growth - %
Earn drops > 5% in 10yrs -  
Beta (60-Mnth) Beta (36-Mnth)
- -
Alpha (60-Mnth) Alpha (36-Mnth)
- -

Mithra Pharmaceuticals S... Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE) - %
Return On Assets (ROA) - %
Net Profit Margin - %
Assets Turnover -  
Return On Equity (ROE) -14.78 %
Return On Investment (ROI) - %
Dividend Payout Ratio - %
Plowback Ratio - %
Growth from Plowback Ratio - %
Net Income of Revenues - %
(Asset Utilisation Multiples)
Shareholders Equity Turnover -  
Fixed Assets Turnover -  
Current Assets Turnover -  
Net Working Capital Turnover -  
Inventory Turnover -  
(Other Operating Ratios)
Total Assets-to-Sales -  
Debtors-to-Sales - %
Debt Collection Period - Days

Mithra Pharmaceuticals S... Dividends

Type Curr. Dividend Amount Period Start Period End Total Dividend Amount
Final EUR - 31 Dec 2014 31 Dec 2015 -
Final EUR - 31 Dec 2013 31 Dec 2014 -

Mithra Pharmaceuticals S... Fundamentals

  31 Dec 2012 (EUR) 31 Dec 2013 (EUR) 31 Dec 2014 (EUR) 31 Dec 2015 (EUR)
Turnover - 100.00% - 100.00% 19.04 100.00% 20.44 100.00% m
Pre Tax Profit - -% - -% -3.15 -16.57% -11.86 -58.02% m
Attributable Profit - -% - -% - -% - -% m
Retained Profit - -% - -% - -% - -% m
Eps – Basic - - -306.79 -0.39
Eps – Diluted - - -306.79 -0.39
Dividends per Share - - - -

Mithra Pharmaceuticals S... Balance Sheet

  31 Dec 2012 (EUR) 31 Dec 2013 (EUR) 31 Dec 2014 (EUR) 31 Dec 2015 (EUR)
MITRA:liab eqMITRA:assets MITRA:liab eqMITRA:assets
  31 Dec 2012 (EUR) 31 Dec 2013 (EUR) 31 Dec 2014 (EUR) 31 Dec 2015 (EUR)
ASSETS
fixed assets  Fixed assets - -% - -% - -% - -% m
intangibles  Intangibles - -% - -% 2.18 13.90% 86.25 41.95% m
fixed investments  Fixed Investments - -% - -% 2.12 13.50% 0.20 0.10% m
current assets - other  Current Assets – Other - -% - -% 4.59 29.23% 10.63 5.17% m
stocks  Stocks - -% - -% 1.76 11.23% 2.80 1.36% m
debtors  Debtors - -% - -% 3.37 21.45% 8.91 4.34% m
cash & securities  Cash & securities - -% - -% 1.68 10.69% 96.79 47.08% m
Other assets - -% - -% 0.25 1.57% 1.13 0.55% m
TOTAL - -% - -% 15.70 100.00% 205.59 100.00% m
LIABILITIES
creditors - short  Creditors – Short - -% - -% 8.52 154.27% 34.54 27.11% m
creditors - long  Creditors – Long - -% - -% 1.65 29.87% 43.65 34.27% m
TOTAL - -% - -% 10.17 184.14% 78.19 61.38% m
EQUITY
Minority Interest - -% - -% -5.52 -100.00% -127.39 -100.00% m
Capital Reserves - -% - -% 5.52 100.00% 127.39 100.00% m
TOTAL - -% - -% 5.52 100.00% 127.39 100.00% m

Mithra Pharmaceuticals S... Cash Flow Statement

31 Dec 2012 (EUR) 31 Dec 2013 (EUR) 31 Dec 2014 (EUR) 31 Dec 2015 (EUR)
Operating CF - - -0.90 -18.67
Investing CF - - -8.51 -33.56
Financial CF - - 9.53 147.35
Net change CF - - 0.12 95.11

Mithra Pharmaceuticals S... Employee Data

31 Dec 2012 (EUR) 31 Dec 2013 (EUR) 31 Dec 2014 (EUR) 31 Dec 2015 (EUR)
Number of employees - - 48.00 66.00
Sales per employee - - 0.40 0.31 m

Data supplied by
ADVFN Advertorial
Your Recent History
EU
MITRA
Mithra Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210616 15:33:16